Manufacturing, Vaccines

Evonik Wins Award at CPHI Milan for Plant-based Parenteral Drug Delivery Adjuvant

October 11, 2024

Evonik won the CPHI Excellence in Pharma Award in the “Sustainability” category in recognition of its plant-based squalene, PhytoSquene, used in parenteral drug delivery applications.

University of Oxford Chemists Develop Method for Vaccine Authenticity Screening

August 30, 2024

The approach makes use of clinical mass spectrometers that are already available in hospitals around the world.

CordenPharma and WACKER Consortium Enters Pandemic Readiness

June 20, 2024

The companies have completed the expansion and qualification phase and now enter a stand-by phase for five years.

Highlighting Personalized mRNA-Based Vaccines for Pancreatic Cancer (ASGCT 2024)

May 25, 2024

In an ASGCT Panel on nucleic acid- and cell-based vaccines in oncology, work on a personalized mRNA vaccine was highlighted.

Increasing mRNA Product Stability with Lyophilization

April 24, 2024

Developing freeze-drying processes requires patience and deep product and process understanding.

Evaluating the Partnership between mRNA and LNPs

April 16, 2024

The LNP success in mRNA vaccines leads to their establishment as a standard in mRNA delivery.

TriLink BioTechnologies Launches Analytical Sciences Center of Excellence

November 02, 2023

The new centralized hub will provide advanced testing of nucleic acids, which is expected to simplify mRNA substance testing.

GSK and Zhifei Partner to Extend the Availability of Shingrix

October 12, 2023

The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China.

2023 Nobel Prize in Medicine Awarded for Development of mRNA Vaccines Against COVID-19

October 04, 2023

The prize was awarded jointly to Katalin Karikó and Drew Weissman for their groundbreaking discovery regarding modification of the bases in mRNA.

Dyadic and bYoRNA Collaborate on Production of mRNA

September 26, 2023

The companies plan on targeting the production of abundant, low-cost messenger RNA from C1-cells.